US2021093254A1PendingUtilityA1
Determining likelihood of an adverse health event based on various physiological diagnostic states
Est. expirySep 27, 2039(~13.2 yrs left)· nominal 20-yr term from priority
Inventors:Shantanu SarkarJodi L. RedemskeVal D. EiseleEduardo N. WarmanJohn E. BurnesJerry D. ReilandBrian B. LeeTodd M. ZielinskiMatthew T Reinke
A61B 5/053A61B 5/686G06F 18/29A61N 1/3956A61N 1/3787A61N 1/37282A61N 1/37247A61N 1/3655A61N 1/36542A61N 1/36535A61N 1/36521A61B 5/361A61B 5/0538A61B 5/02405A61B 5/0205A61B 5/1118A61B 5/7264A61B 5/7275G16H 50/30G06K 9/6296
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Techniques for determining a likeliness that a patient may incur an adverse health event are described. An example technique may include utilizing a probability model that uses as evidence nodes various diagnostic states of physiological parameters, which may include one or more subcutaneous impedance parameters. The probability model may include a Bayesian Network that determines a posterior probability of the adverse health event occurring within a predetermined period of time.
Claims
exact text as granted — not AI-modified1 . A system for monitoring health events, the system comprising:
an implantable medical device (IMD) comprising a plurality of electrodes and configured for subcutaneous implantation in a patient, wherein the IMD is configured to determine one or more subcutaneous tissue impedance measurements via the electrodes; and processing circuitry coupled to the one or more storage devices, and configured to:
determine a respective one or more values for each of a plurality of physiological parameters, the plurality of physiological parameters including one or more subcutaneous tissue impedance parameters determined from the one or more subcutaneous tissue impedance measurements;
identify a diagnostic state for each of the physiological parameters based on the respective values, the diagnostic states defining a plurality of evidence nodes for a probability model; and
determine, from the probability model, a probability score indicating a likelihood that the patient (a) is experiencing an adverse health event or (b) is likely to experience the adverse health event within a predetermined amount of time.
2 . The system of claim 1 , wherein the determined values of the physiological parameters correspond to a preceding timeframe relative to when the probability score is determined.
3 . The system of claim 1 , wherein the physiological parameters include values corresponding to at least one of: heart rate variability (HRV), night heart rate (NHR), patient activity (ACT), atrial fibrillation (AF), R-wave amplitude, heart sounds, or ventricular rate.
4 . The system of claim 1 , wherein the processing circuitry is configured to:
identify, from the respective one or more values for each physiological parameter, a plurality of physiological parameter features that encode amplitude, out-of-normal range values, and temporal changes; and identify the evidence nodes based at least in part on the plurality of physiological parameter features.
5 . The system claim 1 , wherein the probability model is a Bayesian Network comprising at least two child nodes and a parent node.
6 . The system of claim 1 , wherein the processing circuitry is configured to:
determine an input to a first child node of the plurality of evidence nodes based on the respective one or more values of the one or more subcutaneous tissue impedance parameters; and determine an input to a second child node of the plurality of evidence nodes based on a combination of one or more values indicating an extent of atrial fibrillation (AF) in the patient during a time period and one or more values indicating a ventricular rate during the time period.
7 . The system of claim 1 , wherein the probability model is expressed as:
P(d, e 1 , . . . , e N )=P(d)Π i=1 N P(e i |d), wherein P(d) comprises a prior probability value, P(e i |d) comprises a conditional likelihood parameter, d comprises a parent node, and e 1 -e N comprise the evidence nodes.
8 . The system of claim 1 , wherein the processing circuitry is further configured to:
compare the probability score to at least one risk threshold; and determine one of a plurality of discrete risk categorizations based on the comparison.
9 . The system of claim 1 , wherein the processing circuitry is further configured to:
identify an occurrence of missing data, the missing data corresponding to a particular physiological parameter; determine an extent to which the data for the physiological parameter is missing; and determine whether to use the physiological parameter when determining the probability score based on the extent to which the data is missing.
10 . A method comprising:
determining a respective one or more values for each of a plurality of physiological parameters, the plurality of physiological parameters including one or more subcutaneous tissue impedance parameters determined from one or more subcutaneous tissue impedance measurements; identifying a diagnostic state for each of the physiological parameters based on the respective values, the diagnostic states defining a plurality of evidence nodes for a probability model; and determining, from the probability model, a probability score indicating a likelihood that the patient (a) is experiencing an adverse health event or (b) is likely to experience the adverse health event within a predetermined amount of time.
11 . The method of claim 10 , wherein the determined values of the physiological parameters correspond to a preceding timeframe relative to when the probability score is determined.
12 . The method of claim 10 , wherein the physiological parameters include values corresponding to at least one of: heart rate variability (HRV), night heart rate (NHR), patient activity (ACT), atrial fibrillation (AF), heart sounds, or ventricular rate.
13 . The method of claim 10 , further comprising:
identifying, based on the one or more subcutaneous tissue impedance measurements, a periodic variation in subcutaneous tissue impedance; and determining, based on the periodic variation in subcutaneous tissue impedance, a parameter value for at least one of the physiological parameters.
14 . The method of claim 10 , further comprising:
identifying a plurality of physiological parameter features based on the respective one or more values for each physiological parameter, wherein the features are configured to, upon analysis, yield a same number of potential diagnostic states for each physiological parameter; and identifying, from the potential diagnostic states, the diagnostic state for each of the physiological parameters.
15 . The method of claim 10 , wherein the probability model is a Bayesian Network comprising at least two child nodes and a parent node.
16 . The method of claim 10 , further comprising:
determining an input to a first child node of the plurality of evidence nodes based on the respective one or more values of the one or more subcutaneous tissue impedance parameters; and determining an input to a second child node of the plurality of evidence nodes based on a combination of one or more values indicating an extent of atrial fibrillation (AF) in the patient during a time period and one or more values indicating a ventricular rate during the time period.
17 . The method of claim 10 , wherein the probability model is expressed as:
P(d, e 1 , . . . , e N )=P(d)Π i=1 N P(e i |d), wherein P(d) comprises a prior probability value, P(e i |d) comprises a conditional likelihood parameter, d comprises a parent node, and e 1 -e N comprise the evidence nodes.
18 . The method of claim 10 , further comprising:
comparing the probability score to at least one risk threshold; and determining one of a plurality of discrete risk categorizations based on the comparison.
19 . The method of claim 10 , further comprising:
determining, for each of the plurality of physiological parameters, the respective one or more values determined at various frequencies; determining the diagnostic states using the respective one or more values; and storing, to a memory device, at least one of: the respective one or more values or the probability score.
20 . A non-transitory computer-readable storage medium having stored thereon instructions that, when executed, cause one or more processors to at least:
determine a respective one or more values for each of a plurality of physiological parameters, the plurality of physiological parameters including one or more subcutaneous tissue impedance parameters identified from one or more subcutaneous tissue impedance measurements; identify a diagnostic state for each of the physiological parameters based on the respective values, the diagnostic states defining a plurality of evidence nodes for a probability model; and determine, from the probability model, a probability score indicating a likelihood that the patient (a) is experiencing an adverse health event or (b) is likely to experience the adverse health event within a predetermined amount of time.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.